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Abstract
Introduction: Takayasu arteritis (TA) is a chronic vasculitis of unknown origin, affecting mainly the aorta and its
main branches. As a result of the inflammation, stenosis, occlusion or dilatation of the involved vessels may occur
and cause a wide range of symptoms. It has been described in association with various auto-immune disorders
(mainly inflammatory digestive tract diseases). However, only few cases of TA associated with sarcoidosis have
been reported, raising the question of an association by chance.
Case report: We report a case of a 34 year-old woman, with one year history of sarcoidosis, who presented with
asymmetric high hypertension revealing inflammatory humeral, axillary and subclavian arteritis related to TA,
successfully treated by steroid and immunosuppressive therapy(Methotrexate
R).
Conclusion: TA and sarcoidosis may be related, rising the hypothesis that TA or Takayasu arteritis-like
granulomatous vasculitis may be, in fact, a complication of sarcoidosis.
Introduction
Takayasu arteritis (TA) is a chronic inflammatory dis-
ease of large arteries which progressively develop steno-
sis, occlusion or aneurismal degeneration. The clinical
presentation is characterised by an acute phase with
constitutional symptoms, followed, months or years
later, by a chronic phase in which symptoms relate to
fibrosis or occlusion of vessels. Angiography is the gold
standard for diagnosis and for topographical classifica-
tion and it correlates with symptoms and prognosis.
Proinflammatory cytokines and, among these, tumor
necrosis factor-alpha (TNF-alpha) are increased and play
a pathogenetic role in the development of disease.
Laboratory findings are non-specific. Treatment of
active disease is primarily based on corticosteroids but
other immunosuppressive drugs are frequently needed.
Anti-platelets agents, statins and antihypertensive drugs
are frequently considered [1].
Sarcoidosis, too, is a systemic inflammatory disease
which can affect virtually any organ system. The lungs
are most commonly affected, but often there is also
affection of the musculoskeletal system, the cutaneous
and central nervous systems, and the heart. Histology
shows granulomas consisting of a central zone with
macrophages, epithelioid cells, and multinucleated giant
cells in addition to activated CD4 lymphocytes, and a
peripheral zone with macrophages, fibroblasts, and CD4
and CD8 lymphocytes. Inclusion bodies are commonly
found. Vasculitis may be found occasionally in patients
with sarcoidosis. It has not been confirmed, however,
whether vasculitis is a true manifestation of the disease
or an occasional, incidentally concurring abnormality.
Concurrence of sarcoidosis and TA were reported in
few cases.
Case Report
A 34 year old woman was admitted to the hospital with
dyspnea, submandubular gland tumefaction and parotid
swelling.
On physical examination, we found the tumefaction of
the parotid and the submandibular gland. The respira-
tory frequency was 24 cycles per minute. The rest of the
clinical examination was without abnormalities.
Laboratory results were as follows: Haemoglobin 10 g/dl,
white blood cell count (WBC) 11 200/mm3, platelets
450 000/mm3, erythrocyte sedimentation rate (ESR)
76 mm/h, calcium 12 mg/dl (normal: 9-11 mg/dl ). Muscle
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ment components C3 and C4 were negative. The angio-
tensin converting enzyme (ACE) level was 135 UI/L.
Chest radiography showed “Bilateral interstitial invol-
vement”. Thoracoabdominal CT scan showed “Multiple
mediastinal and retroperitoneal lymphadenopathy, with
moderate hepatomegaly”. The respiratory functional test
showed the presence of a restrictive syndrome.
T h el u n gf i b r o s c o p yw a sn o r m a l .T h eb i o p s yc o n -
firmed the presence of a non caseating granuloma in the
bronchial mucosa. The bronchoalveolar lavage showed a
predominantly lymphocytic cell with the elevated Cd4/
CD8 ratio.
Ophthalmological examination confirmed the presence
of dry eye syndrome. There was no uveitis. The salivary
g l a n db i o p s yc o n f i r m e dt h ep r e s e n c eo fag r a n u l o m a
without caseous necrosis.
Sarcoidosis was diagnosed, and the patient received
prednisolone 60 mg/day. After 1 month of treatment, all
complaints have been resolved.
Seven months later, when she received 10 mg/day of
prednisolone, she consulted for respiratory distress. Her
left brachial and radial pulses were absent, and her
blood pressure was 180/120 mm Hg as measured from
t h el e f ta r m .B r u i t sw e r ea u d i b l eo v e rt h ec o u r s eo ft h e
left carotid artery and the left and the right subclavian
artery. The patient had elevated ERS (100 mm/H).
An Ultra Sound Colour Doppler (USCD) was per-
formed showing a circumferential parietal swelling inter-
esting the left subclavian artery reducing his superficies
of 76%, demodulating the Doppler spectrum and edema
of the vessl wall [Figure 1]. These data were confirmed
by MR-agniography.
We diagnosed the patient having TA associated with
sarcoidosis. She received prednisolone 40 mg/day with
Methotrexate 10 mg/week and amlodipine 5 mg/say.
As a response to treatment, blood pressure was nor-
mal 2 weeks after. The USCD control confirmed the
therapeutic benefice showing a reduction of the parietal
anomalies.
Discussion
About a dozen cases of the association TA and sarcoi-
dosis were reported in the literature. [1-6]; some of
them are summarized in table 1. When reviewing 60
patients with TA, Kerr and all found two cases of sar-
coidosis associated with TA (3%) [2]. Weiler and all [1],
noted that the diagnosis of sarcoidosis has generally pre-
ceded (80% cases) TA (2 to 17 years). The discovery of
two contemporary conditions is less usual. Our observa-
tion corroborates these results, since sarcoidosis pre-
ceded by 7 months the onset of TA.
TA can be associated with Crohn’s disease [7], RCH,
systemic lupus erythematosus [8], rheumatoid arthritis,
Wegener’s granulomatosis [1]. In the other hand, coexis-
tence of sarcoidosis with other vasculitis was rarely
reported, such as Wegener’s granulmomatosis and Hor-
ton disease [9].
The association between sarcoidosis and TA or other
forms of aortitis may be rare. However, TA or similar
forms of aortitis are too rare to indicate that the
reported concurrence with sarcoidosis is merely gov-
erned by chance. In fact, all these patients had several
common features: (a) usually sarcoidosis preceded TA;
(b) the time between the diagnosis of sarcoidosis and
that of TA was several years (eight or more) in most of
the patients; (c) the aorta and/or its major branches was
affected; (d) 50% of the patients had uveitis, which is
much less common in frank sarcoidosis; and (e) all
patients responded to glucocorticoid treatment.
Association of TA and sarcoidosis raise a number of
questions of a possible link between these 2 diseases.
Vascular injury (or “granulomatous vasculitis), and espe-
cially the location in the aorta thoracic and/or its
branches, could be a complication in the course of sar-
coidosis [1-3,10]. However, since an association of TA
with other granulomatous vasculitis (Crohn’sd i s e a s e )
has been described, other authors have suggested that
different pathogenic mechanisms might contribute to
the occurrence of this association: Infectious factors
(Mycobacterium tuberculosis, Chlamydia pneumoniae),
genetic factors or immunological disturbances [11,12].
Conclusion
The association between sarcoidosis and TA are rare
but not accidental; complete vascular clinical examina-
tion should be performed in those patients in order to
detect asymptomatic underlying inflammatory arteritis.
The relatively low prevalence of sarcoidosis, and even
more so the rarity of aortitis, suggests that this number
Figure 1 USCD of the right carotid artery showing
circumferential parietal swelling interesting the left subclavian
artery reducing his superficies of 76% and demodulating the
Doppler spectrum.
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we say that sarcoidosis and TA appears to be 2 related
diseases or that Takayasu arteritis or Takayasu arteritis-
like granulomatous vasculitis may be, in fact, a compli-
cation of sarcoidosis?
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Table 1 Features of related cases with coincidence of sarcoidosis and Takayasu arteritis
Author Sex/
Age
(years)
Chronology Clinical complaint Laboratory
results
USCD/CT scan Treatment
Weiler [1] Female/
39
12 year
history of
sarcoidosis
Cardiac failure transient
ischaemic attack
ESR 30 mm/h - Surgery
Glucocorticoid
Kerr [2] Female/
32 ans
Concomitant Polyarthritis, uveitis - Subclavian steal syndrome -
Korkmaz
[3]
Female/
29
4 year
history of
sarcoidosis
Pain in the left arm, 15 kg
weight loss erythema
nodosum diminished left
radial pulse
Haemoglobin 11
g/dl, WBC 15
700/mm3, ESR
70 mm/h.
Complete obstruction of the left subclavian,
left vertebral and superior mesenteric
arteries, and diffuse narrowing in the left
common carotid artery
Azathioprine 150
mg/day+
Prednisolone 60
mg/day
Schapiro
[4]
Female/
42
2 year
history of
sarcoidosis
Arteritis claudication,
stenocardia
- Diffuse narrowing of Aortic bifurcation and
subclavian arteries
Glucocorticoid,
cyclophosphamide
Taeib [5] Female/
11
2 year
history of
sarcoidosis
Headache, hypertension - Stenosis of Aortic arch -
Robaday
[6]
Female/
26
1 year
history of
sarcoidosis
Right painful upper limb Haemoglobin
10,4g/dl, ESR 80
mm/h.
Inflammatory humeral, axillary and
subclavian arteritis
Presdnisolone 55
mg/day
USCD: Ultra Sound Colour Doppler; WBC: white blood cell count; ESR: erythrocyte sedimentation rate.
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